Products for Research Use Only
RegisterLogin

SRI-31255

CAT: 0931-T207344-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T207344-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
905580-86-1
Target
LRRK2
Related Pathways
Autophagy
Bioactivity
SRI-31255 is an orally active LRRK2 inhibitor, with IC50 values of 520 nM for human wild-type (WT) and 427 nM for the G2019S mutant. It inhibits kinase activity by binding to the ATP-binding pocket of LRRK2, providing neuroprotective effects. SRI-31255 serves as a lead compound for developing LRRK2-targeted therapies for Parkinson’s disease research.
Smiles
N([C@@H]1C=2C(CC1)=CC=CC2)C3=C4C(NC=C4)=NC=N3
Molecular Formula
C15H14N4
Molecular Weight
250.3
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T5478-01SRI 31215 TFA
T210311-01SRI-31142
T87438-01SRI-43265
T28852-01SRI-31040
T34706-01SRI-29132
T73286-01SRI-42127
T89043-01SRI-29574
T8801-01SRI-29329
T60004-01SRI-37330
T9662-01SRI 37892

Alternative Products

CatalogName
HY-75368-01SRI-31255
CSB-CL022665HUSRI
BA4890-5SRI-43265
BA6623-100SRI-37240
BA6616-100SRI-41315
70R-20520SRI antibody
HY-175535SRI-32743
HY-175661SRI-22136
HY-117002-01SRI 37892
492821SRI (Sorcin)

Popular Products